Torsten O. Nielsen
0000-0003-3769-2517
Publication & Citation Trends
Publications
0 total
Prosigna Risk of Recurrence score and intrinsic subtypes are associated with adjuvant anthracycline chemotherapy benefit in high-risk breast cancer
Cited by 0
Semantic Scholar
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative.
Cited by 3
Semantic Scholar
Digital Profiling of Immune Biomarkers in Breast Cancer: Relation to Anthracycline Benefit.
Cited by 2
Semantic Scholar
Immune Biomarkers on Tissue Microarray Cores Support the Presence of Adjacent Tertiary Lymphoid Structures in Soft Tissue Sarcoma. OA
Cited by 1
Semantic Scholar
LUMINA: Using molecular biomarkers to guide decision making for breast radiotherapy.
Cited by 4
Semantic Scholar
Breast Cancer Histopathology in the Age of Molecular Oncology.
Cited by 4
Semantic Scholar
Abstract P4-11-06: TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial
Cited by 6
Semantic Scholar
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein. OA
Cited by 31
Semantic Scholar
Research Topics
Breast Cancer Treatment Studies
(181)
Sarcoma Diagnosis and Treatment
(110)
HER2/EGFR in Cancer Research
(79)
Cancer Genomics and Diagnostics
(74)
Advanced Breast Cancer Therapies
(61)
Affiliations
Canadian Institute for Advanced Research
University of North Carolina at Chapel Hill
University of British Columbia Hospital
Dartmouth–Hitchcock Medical Center
BC Cancer Agency